ACTONEL Drug Patent Profile
✉ Email this page to a colleague
When do Actonel patents expire, and when can generic versions of Actonel launch?
Actonel is a drug marketed by Apil and Warner Chilcott and is included in two NDAs.
The generic ingredient in ACTONEL is calcium carbonate; risedronate sodium. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium carbonate; risedronate sodium profile page.
Summary for ACTONEL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 35 |
Patent Applications: | 2,226 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACTONEL |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ACTONEL |
What excipients (inactive ingredients) are in ACTONEL? | ACTONEL excipients list |
DailyMed Link: | ACTONEL at DailyMed |
Recent Clinical Trials for ACTONEL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dong-A ST Co., Ltd. | Phase 4 |
Wake Forest University Health Sciences | Phase 3 |
Weill Medical College of Cornell University | Phase 4 |
Pharmacology for ACTONEL
Drug Class | Bisphosphonate |
Paragraph IV (Patent) Challenges for ACTONEL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ACTONEL | Tablets | risedronate sodium | 150 mg | 020835 | 1 | 2008-08-12 |
ACTONEL | Tablets | risedronate sodium | 75 mg | 020835 | 1 | 2007-09-07 |
ACTONEL | Tablets | risedronate sodium | 5 mg, 30 mg and 35 mg | 020835 | 1 | 2004-04-23 |
US Patents and Regulatory Information for ACTONEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-002 | Apr 14, 2000 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-004 | Apr 16, 2007 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-001 | Mar 27, 1998 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-003 | May 25, 2002 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACTONEL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-001 | Mar 27, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-002 | Apr 14, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-005 | Apr 22, 2008 | ⤷ Try a Trial | ⤷ Try a Trial |
Apil | ACTONEL | risedronate sodium | TABLET;ORAL | 020835-002 | Apr 14, 2000 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ACTONEL
See the table below for patents covering ACTONEL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Argentina | 039978 | TRATAMIENTO Y PREVENCION DE LA OSTEOPOROSIS | ⤷ Try a Trial |
South Korea | 20030097610 | ⤷ Try a Trial | |
Montenegro | 00862 | UPOTREBA BISFOSFONATA ZA PROIZVODNJU LEKA ZA INHIBIRANJE RESORPCIJE KOSTIJU (USE OF A BISPHOSPHNATE IN THE MANUFACTURE OF A MEDICAMENT FOR INHIBITING BONE RESORPTION) | ⤷ Try a Trial |
Denmark | 599685 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACTONEL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1175904 | CA 2007 00045 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ALENDRONSYRE, NATRIUMTRIHYDRAT, OG COLECALCIFEROL |
0998292 | PA2006002 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: NATRIUM ALENDRONICUM/COLECACIFEROLUM; REGISTRATION NO/DATE: EU/1/05/310/001, EU/1/05/310/002, EU/1/05/310/003, EU/1/05/310/004, EU/1/05/310/005 20050824 |
1175904 | C01175904/01 | Switzerland | ⤷ Try a Trial | FORMER OWNER: SCHERING CORPORATION, US |
1175904 | PA2007007 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: ACIDUM ALENDRONICUM NATRIUM, COLECALCIFEROLUM; REGISTRATION NO/DATE: EU/1/05/310/001 2005 08 24 EU/1/05/310/002 2005 08 24 EU/1/05/310/003 2005 08 24 EU/1/05/310/004 2005 08 24 EU/1/05/310/00 20050824 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |